BAX logo

Baxter International Inc. (BAX)

$20.10

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on BAX

Market cap

$10.38B

EPS

-2.15

P/E ratio

--

Price to sales

0.8

Dividend yield

0.199%

Beta

0.645271

Price on BAX

Previous close

$19.66

Today's open

$19.50

Day's range

$19.42 - $20.17

52 week range

$15.73 - $31.76

Profile about BAX

CEO

Andrew P. Hider

Employees

37500

Headquarters

Deerfield, IL

Exchange

New York Stock Exchange

Shares outstanding

516469008

Issue type

Common Stock

BAX industries and sectors

Healthcare

Medical Equipment & Supplies

News on BAX

Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its newly renamed 2025 Sustainability Report, highlighting the company's progress and refreshed approach to advancing a sustainable and responsible business model. “As we shape Baxter's next chapter, our focus remains clear: making a meaningful difference for patients, customers and communities while working to create long‑term value for all stakeholders,” said Andrew Hider, presiden.

news source

Business Wire • Jun 22, 2026

news preview

Baxter's Unit Synovis MCA to Lead Global Rollout of the SHIYA Platform

BAX gains as Synovis MCA signs a multi-year deal to commercialize MediThinQ's SHIYA 3D surgical visualization platform worldwide.

news source

Zacks Investment Research • Jun 19, 2026

news preview

Reasons to Retain Baxter International Stock in Your Portfolio for Now

BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.

news source

Zacks Investment Research • Jun 16, 2026

news preview

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Jun 9, 2026

news preview

Wall Street hated these 15 stocks. Then their earnings proved the analysts wrong.

Earnings beats mean a lot more when it happens to stocks the market gave up on.

news source

Market Watch • Jun 3, 2026

news preview

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Baxter International Inc. (BAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • May 13, 2026

news preview

Baxter International Shareholders Approve Board Slate, Pay and Incentive Plan at Annual Meeting

Baxter International NYSE: BAX held its 2026 annual meeting of stockholders by webcast, with shareholders giving preliminary approval to all five proposals presented by the company, including the election of nine directors, executive compensation, auditor ratification, an amended incentive plan and a change related to board size.

news source

MarketBeat • May 10, 2026

news preview

Baxter International Still Has A Path To Upside

In recent years, stocks like Baxter International have underperformed: most low-growth, high-debt, struggling names have been bad investments at basically any price. Concerns are real, and early missteps under new CEO Andrew Hider haven't helped. But valuation is attractive not just on an absolute basis but also relative to the outlook, and Q1 results seemed helpful to the bull case.

news source

Seeking Alpha • May 8, 2026

news preview

Madison Small Cap Fund Q1 2026 Portfolio Activity

ICU Medical's new high-volume pump has more connected features, which we believe will drive retention rates and incremental revenue. SiteOne Landscape Supply controls 18% of this $26 billion industry and has been growing revenue at a low double-digit compound annual growth rate over the past several years. Madison Small Cap Fund liquidated its position in Globus Medical after a multi-year period because the company's success drove its market cap to $12B.

news source

Seeking Alpha • May 5, 2026

news preview

Baxter beats quarterly expectations on strong demand for medical devices

Baxter on Thursday beat Wall Street estimates for first-quarter profit and revenue, helped by robust sales ​in its medical products and therapies unit.

news source

Reuters • Apr 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Baxter International Inc.

Open an M1 investment account to buy and sell Baxter International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in BAX on M1